Four-dimensional (4D) radiotherapy delivery to dynamically moving tumors requires a real-time signal of the tumor position as a function of time so that the radiation beam can continuously track the tumor during the respiration cycle. The aim of this study was to develop and evaluate an electronic portal imaging device (EPID)-based marker-tracking system that can be used for realtime tumor targeting, or 4D radiotherapy. Three gold cylinders, 3 mm in length and 1 mm in diameter, were implanted in a dynamic lung phantom. The phantom range of motion was 4 cm with a 3-s "breathing" period. EPID image acquisition parameters were modified, allowing image acquisition in 0.1 s. Images of the stationary and moving phantom were acquired. Software was developed to segment automatically the marker positions from the EPID images. Images acquired in 0.1 s displayed higher noise and a lower signal-noise ratio than those obtained using regular ͑Ͼ1 s͒ acquisition settings. However, the markers were still clearly visible on the 0.1-s images. The motion of the phantom blurred the images of the markers and further reduced the signal-noise ratio, though they could still be successfully segmented from the images in 10-30 ms of computation time. The positions of gold markers placed in the lung phantom were detected successfully, even for phantom velocities substantially higher than those observed for typical lung tumors. This study shows that using EPID-based marker tracking for 4D radiotherapy is feasible, however, changes in linear accelerator technology and EPID-based image acquisition as well as patient studies are required before this method can be implemented clinically.
I. INTRODUCTION
Intrafraction organ motion, particularly that caused by respiratory motion, is a significant obstacle to the use of highly conformal fields during radiotherapy. Such motion results in the use of large margins to ensure target coverage. Several methods have been studied to address this issue, including respiratory gating, breath-hold techniques, and fourdimensional (4D) radiotherapy, the focus of this article. 4D radiotherapy can be defined as the "explicit inclusion of the temporal changes of anatomy during the imaging, planning and delivery of radiotherapy". 1 4D radiotherapy can be delivered by moving the radiation beam itself, 2-4 the beamdefining multileaf collimator (MLC), [5] [6] [7] or, in principal, the patient via couch motion.
Electronic portal imaging device (EPID)-based implanted marker tracking for 4D radiotherapy combines several evolving technologies: EPID-based imaging of implanted fiducials, automated marker segmentation, and 4D radiation delivery. The use of implanted fiducial markers for accurate EPID-based target-beam set-up alignment for prostate radiotherapy has been widely reported. [8] [9] [10] [11] [12] [13] [14] [15] Kilovoltage fluoroscopy systems have been used to image implanted fiducial markers for respiratory gated radiotherapy [16] [17] [18] [19] [20] [21] [22] [23] and tumortracking radiotherapy. [2] [3] [4] A schematic diagram of EPID-based implanted markertracking 4D radiotherapy that accounts for intrafraction motion is shown in Fig. 1 . The solid lines indicate the current information flow of the treatment plan to the delivered fields, and the dashed lines indicate the additional information feedback loop required for 4D radiotherapy. "4DC" is the fourdimensional controller, so named because its purpose is to account for the temporal intrafraction motion during radiation delivery. The 4DC takes as input the treatment parameters, such as the MLC planned positions and the targettracking signal. The tracking signal can potentially be any signal related to the tumor motion, such as a spirometer, strain gauge, optical surface-tracking system, electromagnetic radiation system, indoor-global positioning system, etc., though in this case the tracking signals come from the implanted marker positions. The marker positions are determined in the "process signal" box of Fig. 1 (see Sec. II C) based on the images acquired in the "acquire signal" box (see Sec. II B). The 4DC operates on these inputs to produce as output the MLC leaf-motion positions, which track the moving target position. The 4DC may require the prediction of future target positions, depending on the time needed to complete the feedback loop. [24] [25] [26] Prototype software for 4DC has been written, though this is the subject of a separate investigation.
Tumor tracking using dual kilovoltage fluoroscopy has been described by Kitamura et al., 16, 17 Harada et al., 18 Shimizu et al., 19, 20 and Shirato et al. [21] [22] [23] Both tumor tracking using dual fluoroscopy and tumor tracking using an EPID follow internal structures which reduce set-up error, and both have the potential for anatomy tracking without the need for implanted markers. The main differences between dual fluoroscopy and EPID-based tumor tracking are
• Unlike fluoroscopy, EPIDs are generally present on most modern linear accelerators.
• EPIDs do not give extra patient dose.
• EPIDs image the treatment beam itself and do not require an independent radiation source and the associated Quality Assurance work and potential error necessary when aligning the two coordinate systems.
• The EPID provides only 2D positional information, whereas dual fluoroscopy results in 3D positions. However, these directions are perpendicular to the beam central axis, the two most important directions dosimetrically.
• The contrast is significantly lower for million volts (MV) imaging of gold markers rather than Kilo volt imaging of gold markers (the photon mass attenuation coefficient ratio ͑ / ͒ gold / ͑ / ͒ tissue is 30 at 100 keV and 1.0 at 1 MeV), and, thus, the marker-detection algorithms for million volt imaging need to be more robust.
• The EPID is only useful when the treatment beam is on, thus requiring a fast MLC response.
A further discussion on comparing EPID-based marker tracking with dual fluoroscopy-based marker tracking is given in the Sec. IV.
The aim of the current work was to determine the feasibility of using an EPID to track gold markers implanted directly in a lung phantom to facilitate accurate 4D radiotherapy.
II. METHODS AND MATERIALS
In order to achieve the research aim, the following steps were necessary:
• Implanting markers in a motion phantom, • Assessing image quality for single frame ͑0.1 second͒ image acquisition, • Acquiring images of a moving phantom, • Developing image-processing techniques to automatically detect the implanted marker positions, and • Testing the marker-detection method on moving phantom images.
Each of these steps is outlined in detail below.
A. Implanting markers in a motion phantom
Three gold cylinders (MD Industries, Northbrook, IL 60062), 3 mm in length and 1 mm in diameter, were used as markers (see Fig. 2 ). These markers were chosen because their dimensions were considered sufficiently small for implantation via bronchoscopy or percutaneous delivery.
The markers were implanted into the lung block insert of a commercially available intensity modulated radiation therapy (IMRT) dose-verification phantom (Standard Imaging, Inc., Middleton, WI 53562). The three markers were each orientated in a different plane, facilitating both the largest and smallest marker cross section in the beam view and the direction of phantom motion. In addition, a wire strip outlining the edge of the simulated tumor was added to the lung block. The shape of the simulated tumor outline was derived from an actual lung tumor, as shown in Fig. 3 .
The phantom was placed on a low-friction platform and attached to a mechanical sinusoidal oscillator (Fig. 4) . This oscillating generator has been used for previously described respiratory motion simulation studies at our institution. 6, 27 The motion phantom was set with a range of motion of 4 cm and a "breathing" period of 3 s. The rationale for using a large range of motion (larger than that seen in actual lung tumors [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] ) was the ability to simulate a "worst case" scenario. Thus, by interpolation, if EPID-based marker segmentation is achievable for high marker velocities, this technique will be applicable to smaller marker velocities that would be observed clinically. A 4-cm range of motion and a 3-s period corresponds with a maximum velocity of approximately 4 cm s −1 .
B. Acquiring EPID images using modified acquisition settings
All measurements were performed using a Varian (Varian Medical Systems, Palo Alto, CA 94304) 2100 EX linear accelerator operating in the 6-MV photon mode. The images were acquired using the Varian AS-500 electronic portal imaging device attached to the linear accelerator. The experimental setup is shown in Fig. 4 . Only anterior fields were used for this study, though, due to the phantom symmetry, we would expect similar images from the posterior field. The source-to-detector distance was set to 140.0 cm.
To achieve 4D radiotherapy tracking for respiratoryinduced motion, the image acquisition and processing must occur in substantially less time than a breathing period, with a high sampling frequency, preferably 10 Hz or greater. The acquisition settings used for regular clinical image acquisition at our institution average ten individual image frames and take longer than 1 s to acquire. This acquisition time is clearly too long for 4D radiotherapy, and, thus, it was necessary to change the acquisition settings. The minimum acquisition time for the system used is approximately 0.1 s, which is considerably less than a breathing period. However, such current hardware limitations restrict the acquisition of these 0.1-s integrated images to 1 Hz. Thus, although the imager is capable of acquiring 0.1-s images, these images can only be acquired once per second. Nonetheless, since the purpose of this study was to assess the quality of a 0.1-s image to discern the positions of the (moving) markers, the present hardware was deemed acceptable for assessing image quality acceptability for respiratory motion tumor tracking. The main differences in the acquisition settings for our regular clinical image acquisition process at our institution and those used to test the feasibility of EPID-based marker tracking, known as "fast settings," are the number of frame averages (10 to 1), the dose rate ͑100 to 300 MU/ min͒, and the total acquisition time ͑ϳ1.5 to ϳ 0.1 s͒, as shown in Fig. 5 . The dose rate for the fast acquisition settings was also changed from 100 to 300 MU/ min to match that used during conventional treatments in our clinic. The EPID was calibrated before the measurements using the manufacturers' recommended procedure.
In order to evaluate image quality degradation using acquisition settings that obtain images in less time, images of the static phantom were acquired at both regular and fast settings. These images were compared for their ability to clearly visualize and segment the markers.
To evaluate any possible degradation in image quality, caused by respiratory motion during image acquisition, images using the fast acquisition settings were acquired with the phantom moving and were then compared with those acquired using the same settings with the phantom static. Thirty-nine such images of the moving phantom were acquired. 
C. Processing images to automatically detect marker positions
To detect the marker positions automatically, an algorithm was developed and implemented in MATLAB (The Mathworks, Natick, MA 01760-2098). For the morphological operations, a third-party specialized toolbox was used, the Morphology Toolbox for MATLAB (SDC Information Systems, Naperville, IL 60540). The large reduction in gold marker contrast visible on kilovolts compared with million volt images places severe constraints on any automated process for marker segmentation. While a simple threshold transformation based on intensity works reasonably well on images with good contrast, in the case of EPID images acquired with million volt beam, the contrast is insufficient for such a simple approach. Furthermore, the marker motion blurs the markers and makes the segmentation process even more difficult. The marker positions can be visually assessed and manually detected on the images (see later figures), however, an automated procedure is required to obtain subsecond processing time. Since the markers can be visually observed only with proper settings for the gray level and window, and since these settings are different from image to image, the algorithm developed for automatic marker detection is aimed at mimicking the human process of marker detection. A flow diagram of the image-processing steps used for automatic marker-position detection is shown in Fig. 6 .
The first step of the marker detection, as shown in Fig. 6 , is to search only the part of the image where the markers are known to exist. Of course, the whole image could be used as the search area, but limiting the area has two advantages. First, the calculation time required to identify the marker positions decreases dramatically as the search area decreases. Second, restricting the search area to the geographical area where the markers are known to exist reduces the probability of predicting false positive marker positions. The search area on one image is determined manually by drawing a region (via mouse) around the visible markers with a sufficient margin to encompass the maximum expected range of motion of the markers. The same search region is used for subsequent images.
Step 2 of marker detection involves applying a morphological opening. A morphological opening extracts features from a nonuniform background, using a structuring element. By choosing the size and shape of the structuring element, one can construct a morphological operation that is sensitive to specific shapes (rather than intensity levels) in the input image. In this case, the structuring element was formed by three successive Minkowski additions of the elementary square (i.e., the 3 ϫ 3 square centered at the origin) with itself. This process created a 7 ϫ 7 square pixel which is slightly larger than the approximate maximum dimension of the markers in the images. Following the morphological opening, adaptive denoising using a Weiner filter (step 3 of Fig. 6 ) and smoothing using a median filter (step 4) are applied sequentially to isolate the marker levels and the background levels, allowing for easier "blob" detection (step 5). The centroids of the detected blobs are computed and displayed on the image to allow for visual inspection of the success of the algorithm.
D. Implementing a marker detection algorithm for 4D radiotherapy
A flow diagram showing how EPID-based marker tracking could be implemented in a 4D-radiotherapy treatment process is shown in Fig. 7 . The pretreatment steps involve determining the search area from the setup image as discussed above. During treatment, images are acquired and the marker positions identified, which are then used to calculate the appropriate MLC position instructions, which are converted to MLC motion by the MLC controller such that the treatment beam is aligned correctly with the marker positions. This process continues until the desired number of monitor units for the treatment field is delivered.
EPID-based 4D radiotherapy technology is currently unavailable for two reasons. First, though the current image acquisition system can acquire images in 0.1 s, due to buffering time ͑Ͼ1 s͒, the system does not process the acquired images quickly enough to complete the treatment feedback loop (steps 1 through 6) in Fig. 7 in a fraction of a normal respiration cycle. Second, the "Move MLC" interface that takes the calculated positional shifts and transfers these calculated shifts into actual motion during treatment has not yet been developed, though it is the subject of both commercial and academic efforts.
III. RESULTS
EPID images acquired for a static phantom at regular and fast settings are shown in Fig. 8 . An increase in noise is apparent for the fast image, as expected, but the markers and "tumor" edge can be clearly seen.
Images for a sinusoidally oscillating phantom at minimum and maximum velocity positions are shown in Fig. 9 . Substantial blurring of the markers and tumor boundary are seen at maximum velocity, which is approximately 4 cm s −1 , or 4 mm of motion in 0.1 s. Also displayed in Fig. 9 are the automatically detected marker positions.
The image noise and reduction in signal-noise ratio for fast settings and further for dynamically moving phantoms are quantified in Table I . As expected, the noise increases as the image acquisition time decreases, and also the signalnoise ratio decreases as the motion increases.
Since we are currently unable to correlate image acquisition time and phantom motion, to determine the success of the automatically detected marker positions, we relied on visual inspection of each image to ensure that the detected marker positions matched the actual positions (see Fig. 9 ). A further check involved calculating the centroid of the three markers for the dynamic phantom images and comparing these to the centroid found for the static images. A plot of these centroids is displayed in Fig. 10 . All of the centroids calculated from the dynamic phantom images are within the motion limits of the static image centroids in the direction of motion ͑Y͒. Perpendicular to the direction of motion ͑X͒, the dynamic and static centroids agree to within 1 2 of an EPID pixel width ͑0.4 mm͒.
IV. DISCUSSION
As predicted by Battista 38 in 1996, the field of radiotherapy is moving toward the definition of a 4D patient, both for inter-and intrafractional temporal anatomical changes. This article evaluates the feasibility of using an EPID to track internally implanted fiducial markers, acknowledging the current limitation that (a) the image-acquisition system of the EPID used can acquire 10-Hz images but with significant time delays caused by buffering and data transfer and (b) the feedback loop (see Fig. 1 another device assume control of the MLC controller. Depending on the time taken to complete the feedback loop shown in Fig. 1 , it may be necessary to include respiratory prediction software [24] [25] [26] in the 4D controller. Obviously, the faster the loop can be completed, the less prediction is required, thereby reducing the number of errors in the process.
It is envisaged that the hardware limitations will be overcome by technological advances in the next few years, and, thus, MLC-based 4D radiotherapy accounting for intrafraction motion will become a reality. It should be noted here that 4D intrafraction radiotherapy has been successfully performed using a robotic linear accelerator. 39 The limitation of these non-MLC-based devices, apart from their limited availability, is that the beam aperture is limited to circular shapes, which lowers efficiency and leads to longer treatment times.
There are advantages of a dual-fluoroscopy-based system [16] [17] [18] [19] [20] [21] [22] [23] over an EPID-based system. First, with dual fluoroscopy, the tumor position can be determined in three dimensions. This can be performed, in principle, with EPID by determining the relative differences between the marker positions, but the accuracy and precision of the marker detection would have to be extremely high. It is also possible, in principle, for the linac to account for motion in the beam direction by (a) changing the beam aperture and (b) changing the delivered dose based on the inverse square law. In practice, not accounting for movement along the beam direction will yield dosimetric errors of less than a few percent, whereas not accounting for motion perpendicular to the beam direction can yield dosimetric errors of 100%.
A second advantage of a dual-fluoroscopy-based system over an EPID-based system (an advantage that in fact applies to all non-EPID-based patient motion-tracking systems) is that for non-EPID-based systems, the tumor-tracking device is independent of the treatment beam and, therefore, can be turned on independently of the treatment beam, allowing, for example, respiratory-gated treatments. Thus, the patient motion is determined before the irradiation starts. For the EPID, the motion-tracking system is coupled with the radiation beam, and, therefore, without irradiating the patient, the exact position of the tumor is unknown. If a treatment is interrupted for any reason, the same treatment initiation issues will recur. This problem would also make respiratory gating based solely on EPID motion tracking unfeasible. There are two possible solutions to this problem. One is to have a second position-monitoring system independent of the EPID system, which could act as a first guess on tumor position. The targeted treatment would be initiated based on the information of the second monitoring system and then using the EPID signal when possible. The second, and perhaps a more desirable solution to this problem, not requiring an independent monitoring system, is to lower the dose rate (e.g., to 100 monitor units per minute) during the search for the exact seed positions (which should take less than one second), with the dose rate increased to the normal treatment rate when the seeds are successfully being tracked. Such a dose would certainly be acceptable, particularly when two or three port films of 2-3 monitor units are often routinely acquired but not corrected for in the patient's daily dose.
Though there are disadvantages of using the EPID as a position-monitoring system, there are also definite advantages. EPIDs have become standard accessories on most linear accelerators being purchased, and, thus, no further hardware is required. Fluoroscopy delivers unwanted dose, which can be at nontrivial levels due to the need for frequent monitoring to track respiratory motion. Fluoroscopy devices also require calibration and routine quality assurance checking of their coordinate system with the linear accelerator isocenter. This calibration is another source of error, potentially limiting the accuracy of non-EPID devices for motion tracking. With the marker-position detection coupled with the radiation delivery, there are no such sources of error.
It may also be feasible to perform EPID-based tracking for IMRT treatments if advanced image-processing methods are developed that can detect markers even when the MLC leaves are obscuring the markers. Improvements in imageacquisition systems are occurring frequently, both in terms of image quality and also the dose required for an acceptable image.
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V. CONCLUSIONS
A method that automatically detects the positions of implanted markers based on EPID images of dynamic phantoms acquired in 0.1 s has been developed. The use of the 0.1 s image acquisition increased the noise by a factor of four, and reduced the signal-noise ratio by 2/3. The motion blurring effect of the dynamic phantom further reduced the signal-noise ratio by a factor of two. However, the positions of gold markers placed in a lung phantom were successfully detected, even when the phantom was moving with velocities higher than those observed for typical lung tumors. This method shows the feasibility of EPID-based 4D radiotherapy, though it has yet to be tested in patient cases. Before EPIDbased 4D radiotherapy can be implemented clinically, other hardware and software developments are required to both the EPID image-acquisition system and the MLC controller. TABLE I. The noise and signal-noise ratio for clinical (static phantom), fast settings (static phantom), and fast settings (phantom velocity ϳ4 cm s −1 ). The noise is defined as the standard deviation of the pixel-pixel variations in a uniform region. The signal-noise ratio is defined as the ratio of the difference between the maximum pixel value for the marker and the background divided by the noise. 
